Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

sm

Steve Mott joins DrugLogic

October 5, 2011 Research and Development appointment, outcomes research, personalised medicine, pharmacovigilance, research and development

Former Datapharm Communications chief executive Steve Mott has been apppointed UK managing director by DrugLogic.The US firm develops analytical tools …
Appointment

Contract research news in brief

October 5, 2011 Research and Development research and development news

Clinipace raises $15m, PPD appoints a new chief executive and there are updates from Quintiles, PharmaNet and DaVita Clinical Research. …
News
adaptimmune_helen_tm1

Adaptimmune makes board appointments

October 4, 2011 Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development

UK and US-based cell therapy company Adaptimmune has made two new appointments to its board. Dr Jonathan Knowles joins as …
Appointment

Trial disappointment for AZ lung cancer drug

October 3, 2011 Research and Development, Sales and Marketing AstraZeneca, selumetinib

AstraZeneca’s lung cancer drug selumetinib has failed to hit its primary endpoint in a Phase II trial. The trial compared …
News

Chiltern expands North American Operation with a new office in Illinois

September 30, 2011 Research and Development

 Mr. Barry Simms, Chiltern’s Country Manager, North America, commented, “Chiltern continues to look for opportunities to increase our strategic footprint …
News
Press release

Astellas abandons oral anticoagulant darexaban

September 30, 2011 Research and Development Astellas, Eliquis, Xarelto, darexaban

Astellas Pharma has abandoned the development of its oral direct factor Xa inhibitor darexaban. The Japanese firm blamed both the …
News

R&D jobs in emerging markets – leaders wanted

September 29, 2011 Business Services, Research and Development Jobs, careers, pharma jobs

The globalisation of pharmaceutical research and development is creating a wave of job opportunities in emerging markets such as India …
Feature

NICE blames pharma R&D model for spiralling cancer drug costs

September 29, 2011 Research and Development, Sales and Marketing Cancer, NICE, clincial trials

NICE has blamed the pharma industry’s ‘inefficient’ and increasingly costly R&D model for the rising price of cancer drugs. NICE …
News

Researchers call for European clinical trial reform

September 28, 2011 Research and Development Euorpe, clinical trials

Medical researchers are calling for regulatory red tape to be snipped away from the legal requirements around clinical trials in …
News

Lilly launches ‘open innovation’ drug discovery

September 28, 2011 Research and Development OIDD, TB, lilly

Lilly has launched a new open innovation platform designed to help build its pipeline and to identify new treatments for …
News

Roche’s Herceptin successor impresses at EMCC

September 27, 2011 Research and Development Herceptin, Roche, TDM-1

Roche’s next-generation breast cancer drug T-DM1 has impressed at the European cancer congress after besting Herceptin in a new study. …
News
Boehringer Ingelheim

Boehringer to create biosimilars division

September 27, 2011 Research and Development Boehringer, biosimilars

Boehringer Ingelheim is to tap into the growing interest in biosimilars with the creation of a division dedicated to that …
News

Healthcare 2025: what the future holds for pharma

September 22, 2011 Manufacturing and Production, Research and Development, Sales and Marketing NHS reform, healthcare reform, healthcare spending, prescribing

We are in the middle of a huge upheaval where everything we know is being turned on its head. Welcome …
Feature

Sanofi spots acne vaccine opportunity

September 22, 2011 Research and Development Sanofi, acne, dermatology

Sanofi Pasteur has signed a new research deal with the University of California, San Diego for its investigational acne vaccine. …
News
President Obama

Obama proposes seven year rule for biologics

September 21, 2011 Research and Development, Sales and Marketing Obama, biologics

President Obama has returned to the issue of market exclusivity for biologic drugs as a way of cutting healthcare costs. …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026